Upcoming events

Switch to Calendar View

• Building a Canadian Community of SOTL Practice: From curiosity to inquiry

  • When
    Thursday, October 23, 2025
  •  
    12:00 PM - 1:30 PM
  • Location
    Zoom (Link will be sent close to the event)

  Register

  

  Are you already a published scholar, or perhaps are you just getting started or not quite sure? Whichever the case, we invite you to join our inaugural Community of Practice titled: Building a Canadian Community of SOTL Practice: From curiosity to inquiry

  
  

  on

  Thursday Oct 23, 2025

  9 AM PT / 10 AM MT / 11 PM CT / 12 PM ET / 1 PM AT / 1:30 PM NT

  
  

  
  

  The Symposium will be 1.5 hours long and is open to everyone involved in pharmacology education.

  
  

  The CSPT Education Committee is excited to launch a Community of Practice focused on the Scholarship of Teaching and Learning (SOTL) in Pharmacology.  

  
  

  This opportunity is to connect with those with shared teaching and learning experience across Canada and share ideas and problem solving while developing and promoting excellence and teaching, learning and scholarship across Canadian Pharmacology and related medical science disciplines.

  
  

  There will be 4 sessions over the next 6 months that will allow faculty, researchers and others interested in Pharmacology (and related medical sciences) educational research with a goal to help you develop and elevate your work for career next steps, publishing and/or presenting nationally or internationally.

  
  

  CoP#1 Thursday Oct 23, 2025: Building a Canadian Community of SOTL Practice: From Curiosity to Inquiry

  
  

  CoP#2: Tuesday, December 2, 2025, 12pm (EST): From Silos to Synergy- Connecting Educators on SOTL Topics from Across Canada

  
  

  CoP #3: Tuesday Jan 27 2026, 1:30 pm (EST): Sharing Hurdles and High Fives: Sharing Expertise and Overcoming Challenges

  
  

  CoP#4: Thursday March 12 2026, 1:30 pm (EST): Celebrate and Elevate: Showcasing your SOTL Through Dissemination

  Show details
• The Debate on Acetaminophen Use in Pregnancy and Neurodevelopmental Disorders: Facts or Fiction?

  • When
    Tuesday, November 18, 2025
  •  
    12:00 PM - 1:00 PM
  • Location
    Zoom (Link will be sent close to the event)
  • Spaces left
    51

  Register

  
  

  Register to join us for our next CSPT members' webinar!

  
  

  “The Debate on Acetaminophen Use in Pregnancy and Neurodevelopmental Disorders: Facts or Fiction?”

  
  

  Hear from

  Anick Bérard, PhD FCAHS FISPE 

  Canada Research Chair Tier 1 on Medications and Pregnancy, Faculty of Pharmacy, University of Montreal. Principal Investigator in Canadian Mother-Child Initiative on Drug Safety in Pregnancy. Director at Research Unit on Medications and Pregnancy, Research Center - CHU Sainte-Justine

  
  

  Dr. Bérard has cross-training in epidemiology, pharmacoepidemiology, and genetics from McGill University, and Harvard Medical School. She is full professor of perinatal epidemiology at the University of Montreal, Faculty of Pharmacy, and CHU Ste-Justine in Montreal; and adjunct professor at the Faculty of Medicine of the Université Claude Bernard in Lyon, France, and at the Université Paris Cité, Paris, France. Dr Bérard holds a Canada Research Chair Tier 1 on Medications and Pregnancy; and University of Montreal’s Louis-Boivin research chair on « Medications, pregnancy and lactation ». Dr Bérard is a Fellow of the Canadian Academy of Health Science, and of the International Society of Pharmacoepidemiology; and a voting member of the Birth Defects Research Society.

  
  

  Dr Bérard is the principal investigator of the Canadian Mother-Child Initiative on Drug Safety in Pregnancy (CAMCCO Research/Training/Knowledge Dissemination). She has published over 230 scientific papers, and 2 patents; she has obtained over 37 million dollars in funding from CIHR, CFI, and FRQS as principal investigator. She recently received a Most Distinguished Scientist Award from the Society for Birth Defects Research and Prevention for her work on antidepressants, maternal depression, and pregnancy; and a research career award from the Association of Faculties of Pharmacy of Canada. She is a member of the Agence Nationale sur la Sécurité des Médicaments in France, where she is involved in decision making regarding medication safety in pregnancy, including antidepressants.

  Show details